文献速递免疫规划卫生政策与健康促进慢病防控与筛查

为健康老龄化预防传染病:VITAL公私合作项目

Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project.
PubMed 文献 · Vaccine · 2020-07-24

VITAL项目由17个学术与研究机构及公共研究所、7个产业合作方共同参与,旨在应对老年人群疫苗保护效果减弱与接种率下降的挑战。项目采用整体性、多学科方法与新分析方法,围绕四个支柱开展研究,为欧洲国家制定针对老年人的免疫规划提供工具与证据。

要点

  • VITAL项目聚焦老年成人疫苗可预防疾病负担评估与免疫衰老机制解析。
  • 项目分析疫苗接种策略的临床与经济公共卫生影响,并开发面向医护人员的教育资源。
  • 目标是为欧洲国家地方决策者提供工具,支持制定有针对性、可负担且可持续的老年免疫规划。

核心结论

  • 通过免疫接种预防不断增长的老年成人群体传染病,对改善健康老龄化至关重要。
  • VITAL项目旨在为地方决策者提供循证知识,并开发可用于欧洲国家老年成人针对性免疫规划的工具。
  • 项目结束时,应形成清晰、详细且整合的方案,用于实施一致、可负担且可持续的老年成人疫苗接种策略,并定期评估其随时间推移的影响。

研究设计与样本

  • VITAL(Vaccines and InfecTious diseases in the Ageing popuLation)项目为公私合作项目,合作方包括来自17个学术与研究机构及公共研究所的伙伴,以及7个产业合作方。
  • 项目采用整体性与多学科方法及新分析方法,基于四个支柱开展研究。

主要发现

  • 该年龄组许多已获批并推荐的疫苗因免疫应答下降(免疫衰老)而显示保护效果减弱的迹象,且疫苗接种率下降。
  • 当前主要挑战是提高疫苗有效性与接种率,并为该年龄组部署高效的疫苗接种策略。
  • 四个支柱分别关注:评估老年成人疫苗可预防疾病负担、解析免疫衰老机制、分析疫苗接种策略的临床与经济公共卫生影响、开发面向医护人员的教育资源。

临床怎么用

  • 项目产出面向地方决策者,用于开发欧洲国家老年成人针对性免疫规划。
  • 项目结束时拟提供整合方案,支持实施一致、可负担且可持续的老年成人疫苗接种策略,并定期评估其影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prevention of infectious diseases through immunisation of the growing ageing adult population is essential to improve healthy ageing. However, many licenced and recommended vaccines for this age group show signs of waning of the protective effect due to declining immune responses (immuno-senescence) and decreasing vaccine uptake. Today's major challenge is to improve vaccine effectiveness and uptake and to deploy efficient vaccination strategies for this age group. The Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project, with partners from 17 academic & research groups and public institutes as well as seven industry collaborators, aims to address this challenge. The ambition is to provide evidence-based knowledge to local decision makers. Using a holistic and multidisciplinary approach and novel analytical methods, VITAL will provide tools that allow the development of targeted immunisation programs for ageing adults in European countries. The project is based on four pillars focussing on the assessment of the burden of vaccine-preventable diseases in ageing adults, the dissection of the mechanisms underlying immuno-senescence, the analysis of the clinical and economic public health impact of vaccination strategies and the development of educational resources for healthcare professionals. By the end of the project, a clear, detailed, and integrated program should be available for implementing a consistent, affordable, and sustainable vaccination strategy for ageing adults with regular evaluations of its impact over time.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Van Baarle D, Bollaerts K, Del Giudice G, et al. Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project. Vaccine. 2020. PMID: 32713682. doi:10.1016/j.vaccine.2020.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。